Prof Peter J Shaw is a senior staff specialist in Paediatric Blood Transplant and Cell Therapies (BTCT) at the Children’s Hospital at Westmead and past Clinical Professor in the Speciality of Child and Adolescent Health, Faculty of Medicine and Health at The University of Sydney. He has over 40 years of clinical experience in paediatric bone marrow, blood and cell transplant. His first exposure to BMT was at Westminster Children’s Hospital, the site of the earliest BMTs in the UK for inborn errors such as MPS 1 and Gaucher’s disease; so, his first exposure to allogeneic cell therapies. His primary research has been in improving patient outcomes through optimising conditioning, and this is as applicable to autologous gene modified stem cell therapy as it is to allogeneic transplantation.